Gemcitabine 38 mg/mL

Gemcitabine 38 mg/mL is an injectable solution used for various medical treatments. This single-dose vial is manufactured by Hospira, Inc. and is intended for intravenous administration.

Gemcitabine 38 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Gemcitabine used for?' It is commonly prescribed for cancers such as lung, breast, ovarian, and pancreatic cancer. The specific uses of Gemcitabine 38 mg/mL can vary based on individual patient needs and medical history.

Common effects of Gemcitabine 38 mg/mL may include fatigue, nausea, and a decreased appetite. Some patients may experience hair loss or changes in their blood cell counts. These effects can vary in severity and duration, depending on the individual and their treatment plan. It's important to discuss any concerns with a healthcare provider.

Gemcitabine 38 mg/mL should be handled with care, as it is a potent medication. It is crucial to follow proper storage and disposal guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment. Pregnant women should avoid handling this medication due to potential risks.

Gemcitabine 38 mg/mL may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with Gemcitabine, so it's best to consult with a healthcare professional before combining treatments.